Guenther Schmutz
About
In The Last Decade
Guenther Schmutz
19 papers receiving 423 citations
Peers
Comparison fields: 5 of 47
- Infectious Diseases 244
- Epidemiology 233
- Hepatology 202
- Emergency Medicine 116
- Virology 107
Countries citing papers authored by Guenther Schmutz
This map shows the geographic impact of Guenther Schmutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guenther Schmutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guenther Schmutz more than expected).
Fields of papers citing papers by Guenther Schmutz
This network shows the impact of papers produced by Guenther Schmutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guenther Schmutz. The network helps show where Guenther Schmutz may publish in the future.
Co-authorship network of co-authors of Guenther Schmutz
This figure shows the co-authorship network connecting the top 25 collaborators of Guenther Schmutz. A scholar is included among the top collaborators of Guenther Schmutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guenther Schmutz. Guenther Schmutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 14 | |
| 4 | 75 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 40 | |
| 9 | 44 | |
| 10 | 66 | |
| 11 | 17 | |
| 12 | 30 | |
| 13 | 92 | |
| 14 | 21 | |
| 15 | 1 | |
| 16 | 8 | |
| 17 | Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC. | 12 |
| 18 | [Hepatitis secondary to current non-steroidal anti-inflammatory agents]. | 6 |
| 19 | [Abetalipoproteinemia. Apropos of 2 cases]. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.